Mitzi Williams

862 total citations
37 papers, 461 citations indexed

About

Mitzi Williams is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Mitzi Williams has authored 37 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 10 papers in Public Health, Environmental and Occupational Health and 7 papers in Oncology. Recurrent topics in Mitzi Williams's work include Multiple Sclerosis Research Studies (22 papers), Polyomavirus and related diseases (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). Mitzi Williams is often cited by papers focused on Multiple Sclerosis Research Studies (22 papers), Polyomavirus and related diseases (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). Mitzi Williams collaborates with scholars based in United States, Switzerland and United Kingdom. Mitzi Williams's co-authors include Lilyana Amezcua, Adil Javed, Kristin E. Larsen, Jennifer Smrtka, Omar Khan, Lara M. Stepleman, Suzanne Smith, Abiodun Akinwuntan, Saúl Reyes and Farrah J. Mateen and has published in prestigious journals such as Neurology, The Lancet Neurology and Archives of Physical Medicine and Rehabilitation.

In The Last Decade

Mitzi Williams

34 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mitzi Williams United States	13	328	75	62	62	55	37	461
Dirk Schriefer Germany	13	292 0.9×	46 0.6×	38 0.6×	60 1.0×	74 1.3×	33	460
Howard Zwibel United States	9	430 1.3×	63 0.8×	63 1.0×	47 0.8×	142 2.6×	12	512
Marguerite Duggan Ireland	11	285 0.9×	39 0.5×	60 1.0×	28 0.5×	64 1.2×	14	350
Dhelia Williamson United States	12	203 0.6×	34 0.5×	78 1.3×	74 1.2×	76 1.4×	34	639
James Twiss United Kingdom	17	141 0.4×	27 0.4×	87 1.4×	24 0.4×	29 0.5×	45	746
Michael W. Pill United States	9	285 0.9×	88 1.2×	92 1.5×	87 1.4×	93 1.7×	10	531
Jonathan Hosey United States	3	433 1.3×	121 1.6×	89 1.4×	88 1.4×	127 2.3×	5	505
Hollie Schmidt United States	8	229 0.7×	53 0.7×	58 0.9×	94 1.5×	47 0.9×	20	413
S. B. Glad Norway	11	444 1.4×	60 0.8×	109 1.8×	12 0.2×	130 2.4×	13	583
Amy Perrin Ross United States	12	265 0.8×	59 0.8×	61 1.0×	47 0.8×	76 1.4×	35	425

Countries citing papers authored by Mitzi Williams

Since Specialization

Citations

This map shows the geographic impact of Mitzi Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitzi Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitzi Williams more than expected).

Fields of papers citing papers by Mitzi Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitzi Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitzi Williams. The network helps show where Mitzi Williams may publish in the future.

Co-authorship network of co-authors of Mitzi Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Mitzi Williams. A scholar is included among the top collaborators of Mitzi Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitzi Williams. Mitzi Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Butzkueven, Helmut, Cristoforo Comi, Kathleen Costello, et al.. (2025). Brain health – time matters: multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and related conditions. 2024 report. Multiple Sclerosis and Related Disorders. 101. 106456–106456.

Williams, Mitzi, Lilyana Amezcua, Stanley Cohan, et al.. (2024). Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups. Neurology. 103(3). e209610–e209610. 3 indexed citations

Amezcua, Lilyana, Dalia Rotstein, Afsaneh Shirani, et al.. (2024). Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and Australasia. The Lancet Neurology. 23(10). 1050–1062. 5 indexed citations

Williams, Mitzi, et al.. (2024). Walking and physical performance in black and white adults with multiple sclerosis controlling for social determinants of health. Multiple Sclerosis and Related Disorders. 83. 105439–105439. 2 indexed citations

Williams, Mitzi, Anne H. Cross, Nancy Monson, et al.. (2023). Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial. Multiple Sclerosis and Related Disorders. 76. 104794–104794. 8 indexed citations

Williams, Mitzi, Lilyana Amezcua, Ángel Chinea, et al.. (2023). Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM. Neurology and Therapy. 12(5). 1669–1682. 6 indexed citations

Marrie, Ruth Ann, Jeremy Chataway, Barbara E. Bierer, et al.. (2023). Enhancing diversity of clinical trial populations in multiple sclerosis. Multiple Sclerosis Journal. 29(9). 1174–1185. 19 indexed citations

Amezcua, Lilyana, et al.. (2023). Impact of adherence to disease modifying therapies on long-term clinical and economic outcomes in multiple sclerosis: A claims analysis of real-world data. Multiple Sclerosis and Related Disorders. 77. 104866–104866. 3 indexed citations

Hersh, Carrie M., et al.. (2023). Diversity, Equity, and Inclusion in the Multiple Sclerosis Community: A Call to Action. International Journal of MS Care. 25(5). 199–205. 4 indexed citations

10.

Wiendl, Heinz, Laura Airas, Tanuja Chitnis, et al.. (2023). Phase 3 REMODEL I/II Trials: Efficacy, Safety, and Tolerability of Remibrutinib in Patients with Relapsing Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 80. 105315–105315. 1 indexed citations

11.

Williams, Mitzi, et al.. (2023). Multiple Sclerosis in Black and Hispanic Populations. Neurologic Clinics. 42(1). 295–317. 9 indexed citations

12.

Dobson, Ruth, Dylan R. Rice, Marie D’hooghe, et al.. (2022). Social determinants of health in multiple sclerosis. Nature Reviews Neurology. 18(12). 723–734. 65 indexed citations

13.

Amezcua, Lilyana, Anne H. Cross, Nancy Monson, et al.. (2022). Demographics and Baseline Disease Characteristics of Black and Hispanic Patients With Multiple Sclerosis in the CHIMES Trial (P4-4.005). Neurology. 98(18_supplement). 1 indexed citations

14.

Delgado, Silvia, Mitzi Williams, Morten Bagger, et al.. (2021). Comparable Ofatumumab Treatment Outcomes in Patients across Racial/Ethnic Groups in the ASCLEPIOS I/II and APOLITOS studies (4139). Neurology. 96(15_supplement). 2 indexed citations

15.

Cree, Bruce, Ashish Pradhan, Jinglan Pei, & Mitzi Williams. (2021). Efficacy and safety of ocrelizumab vs interferon beta-1a in participants of African descent with relapsing multiple sclerosis in the Phase III OPERA I and OPERA II studies. Multiple Sclerosis and Related Disorders. 52. 103010–103010. 13 indexed citations

16.

Shin, Robert K., Kottil Rammohan, & Mitzi Williams. (2021). Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis. Neurology and Therapy. 10(2). 415–425. 5 indexed citations

17.

Williams, Mitzi, Lilyana Amezcua, Darin T. Okuda, et al.. (2020). Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM. Neurology and Therapy. 9(2). 483–493. 21 indexed citations

18.

Amezcua, Lilyana, Regina Berkovich, Ángel Chinea, et al.. (2019). Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study). Neurology and Therapy. 8(2). 367–381. 8 indexed citations

19.

Akinwuntan, Abiodun, et al.. (2013). Improvement of Driving Skills in Persons With Relapsing-Remitting Multiple Sclerosis: A Pilot Study. Archives of Physical Medicine and Rehabilitation. 95(3). 531–537. 16 indexed citations

20.

Williams, Mitzi, Marietta Ambrose, Arthur M. Carlin, James G. Tyburski, & Christopher P. Steffes. (2004). Evaluation of academic and community surgery clerkships at a Midwestern medical school. Journal of Surgical Research. 116(1). 11–13. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact